---
title: First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)
description: First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)
image: https://news.3dmatrix.com/hubfs/Robotic%20Surgery2.png
---

![](https://news.3dmatrix.com/hubfs/Robotic%20Surgery2.png)

# First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)

 Published by [ 3-D Matrix ](https://news.3dmatrix.com/author/3-d-matrix) on  Oct 25, 2022 9:02:43 AM

The use of Transoral Robotic surgery (TORS) is increasingly growing in Head and Neck and in Ear, Nose and Throat Surgery. TORS constitutes a viable treatment option, enabling access to difficult-to-reach cancers. However, the technique also brings some risks, including post-operative haemorrhage (incidence rate 4.1%-9.8%).

In the publication *“[Evaluating the role of the self-assembling topical haemostat PuraBond in Transoral Robotic Surgery (TORS) for oropharyngeal cancer: A case series](https://pubmed.ncbi.nlm.nih.gov/36045860/)”* (Ann Med Surg, 2022) by Dr Mriganka De *et al.*, the investigators evaluated the potential benefits of the use of [PuraBond](https://3dmatrix.com/products/purabond/) in 12 patients undergoing TORS surgery for Human Papilloma Virus (HVP) positive oropharyngeal squamous cell carcinoma.

After the completion of the resection and adequate haemostasis was achieved, 3 ml of PuraBond was applied to the surgical bed of the TORS resection site.

The outcome measures included post-operative haemorrhage rates and post-operative complications and requirements.

The results were as follows (% patients):

- Primary haemorrhage (within 24h): 0%
- Secondary haemorrhage (within 30 days): 0%
- Requirement of feeding tube: 0%
- Requirement of tracheostomy: 0%
- Average length of hospital stay (days): 2.87
- Hospital readmission: 0%
- Swallowing outcomes: 100% resumed an oral diet on day 1 post-TORS
- Reported ‘easy’ application of PuraBond: 100%

This study supports the feasibility and safety of PuraBond use in TORS in view of the promising early findings, especially with regard to post-operative haemorrhage rates and swallowing outcomes, both Key Performance Indicators (KPIs) for TORS.

Further studies with extended follow-up are required to better define whether the known haemostatic and regenerative properties of PuraBond translate into direct patient benefits in TORS.

To read the full article click [here.](https://pubmed.ncbi.nlm.nih.gov/36045860/)

 

Tags: [haemostat](https://news.3dmatrix.com/tag/haemostat), [3dmatrix](https://news.3dmatrix.com/tag/3dmatrix), [ent](https://news.3dmatrix.com/tag/ent), [purabond](https://news.3dmatrix.com/tag/purabond), [clinical studies](https://news.3dmatrix.com/tag/clinical-studies), [peptide](https://news.3dmatrix.com/tag/peptide), [bleeding management](https://news.3dmatrix.com/tag/bleeding-management), [transoral surgery](https://news.3dmatrix.com/tag/transoral-surgery), [robotic surgery](https://news.3dmatrix.com/tag/robotic-surgery)

[Back to Blog](https://news.3dmatrix.com)

## Related Articles

<https://news.3dmatrix.com/purastat-for-effective-management-of-post-endoscopic-sphincterotomy-oozing-bleeding-a-case-series>

## [Endoscopic retrograde cholangiopancreatography - PuraStat for effective management of post endoscopic sphincterotomy oozing bleeding: a case series](https://news.3dmatrix.com/purastat-for-effective-management-of-post-endoscopic-sphincterotomy-oozing-bleeding-a-case-series)

 Endoscopic sphincterotomy (EST) is frequently performed during endoscopic retrograde...

[Read More ](https://news.3dmatrix.com/purastat-for-effective-management-of-post-endoscopic-sphincterotomy-oozing-bleeding-a-case-series)

<https://news.3dmatrix.com/first-clinical-data-demonstrating-purastats-safety-and-efficacy-for-haemostasis-in-cervical-endocrine-surgeries-such-as-thyroidectomy-and-parathyroidectomy.-a-ca-1650985657063>

## [First clinical data demonstrating PuraStat’s safety and efficacy for haemostasis in thyroidectomy and parathyroidectomy. A case series of 353 patients.](https://news.3dmatrix.com/first-clinical-data-demonstrating-purastats-safety-and-efficacy-for-haemostasis-in-cervical-endocrine-surgeries-such-as-thyroidectomy-and-parathyroidectomy.-a-ca-1650985657063)

 Cervical endocrine surgeries such as thyroidectomy and parathyroidectomy can carry the risk of...

[Read More ](https://news.3dmatrix.com/first-clinical-data-demonstrating-purastats-safety-and-efficacy-for-haemostasis-in-cervical-endocrine-surgeries-such-as-thyroidectomy-and-parathyroidectomy.-a-ca-1650985657063)

<https://news.3dmatrix.com/comparison-of-endoscopic-hemostasis-for-endoscopic-sphincterotomy-bleeding-between-a-novel-self-assembling-peptide-and-conventional-technique>

## [Promising new study evaluating safety and haemostatic efficacy in Endoscopic Retrograde Cholangiopancreatography (ERCP) for Post-Sphincterotomy bleeding](https://news.3dmatrix.com/comparison-of-endoscopic-hemostasis-for-endoscopic-sphincterotomy-bleeding-between-a-novel-self-assembling-peptide-and-conventional-technique)

 Endoscopic sphincterotomy (EST) is often performed before bile duct stone removal or metallic stent...

[Read More ](https://news.3dmatrix.com/comparison-of-endoscopic-hemostasis-for-endoscopic-sphincterotomy-bleeding-between-a-novel-self-assembling-peptide-and-conventional-technique)

- <https://www.linkedin.com/company/3-d-matrix-europe>
- <https://twitter.com/3dm_emea>
- <https://www.facebook.com/3dmatrixemea>
- <https://www.youtube.com/channel/UCAL-yW5rvDD64iGxj9gJ73g>